Stockreport

Bellerophon to Present New Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual...

Bellerophon Therapeutics, Inc.  (BLPH) 
Last bellerophon therapeutics, inc. earnings: 4/6 10:23 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bellerophon.com
PDF Results to be Presented in Late-Breaking Abstract as an Oral Presentation Presentation Will Also be Published in the Highlights from CHEST Special Edition WARREN, N. [Read more]